Moneycontrol PRO
Upcoming Event:Attend Algo Convention Live, 2 Days & 12+ Speakers at best offer Rs.999/- for Moneycontrol Pro subscribers. Price Increasing Soon!
you are here: HomeNewsWorld

EU okays new J&J COVID vaccine production site

In a statement Friday, the EU drug regulator said the new site in Anagni, Italy, will finish manufacturing of the J&J vaccine, which was licensed for use in adults across Europe in March.

June 26, 2021 / 08:19 AM IST
In a statement, China's Foreign Ministry said it did not see a link between the recent COVID-19 outbreaks and its vaccines. (Representative image)

In a statement, China's Foreign Ministry said it did not see a link between the recent COVID-19 outbreaks and its vaccines. (Representative image)

The European Medicines Agency has approved a new manufacturing site for Johnson & Johnson''s COVID-19 vaccine, in a move that should boost production of the one-dose vaccine across the 27-nation EU.

In a statement Friday, the EU drug regulator said the new site in Anagni, Italy, will finish manufacturing of the J&J vaccine, which was licensed for use in adults across Europe in March.

Production problems have stalled J&J''s roll-out across the European Union in recent months and millions of doses made at a U.S. factory had to be thrown out after contamination issues.

The EU has ordered 200 million doses of the J&J vaccine and was expecting 55 million by the end of June; to date, fewer than 14 million doses have been distributed.

J&J''s vaccine roll-out was also stalled after the EMA concluded there was a “possible link” between the coronavirus shot and very rare blood clots and recommended that a warning should be added to the label. Health officials say the vaccine''s benefits still far outweigh the risks.



Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

PTI
first published: Jun 26, 2021 08:19 am
Sections
ISO 27001 - BSI Assurance Mark